News

News: Industries

The Icelandic Medicines Agency starts publishing educational materials on its medicinal product information website - 28.11.2017

Following a successful pilot project, the Icelandic Medicines Agency has decided to start publishing aRMM educational materials on its website: www.serlyfjaskra.is.

Receipt of clinical trial applications (CTA) summer 2014 - 27.2.2014

Due to summer holiday the Icelandic Medicines Agency (IMA) will not confirm receipt of clinical trial applications (CTA) from 23 June to 11 August 2014.

Fighting availability problems - 4.9.2013

IMA has informed of and promoted how easy it is to market medicinal and veterinary medicinal products in Iceland, not the least by using multilingual packages.

IMA's Annual Report 2012 - 12.7.2013

IMA's Annual Report 2012 has been published on the website

Rules on reduction of fees collected by IMA - 2.7.2013

Rules concerning reduction of fees collected in accordance with Tariff 635/2011 have been changed.

Updated - Receipt of clinical trial applications (CTA) summer 2013 - 1.7.2013

Due to summer holiday the Icelandic Medicines Agency (IMA) will not confirm receipt of clinical trial applications (CTA) from 1. July to 16. August 2013.

New guidelines concerning publication of information in the Drug Catalogue and Price list. - 10.6.2013

A new form has been published.

IMA publishes data about drug consumption in Iceland - 29.5.2013

The published data contains information about drug consumption in Iceland from 2008-2012.

Revocation of S - classification postponed. - 10.5.2013

The Icelandic Medicines Agency postpones revocation of S – classification of certain medicinal products.

Rules concerning reduction of fees collected in accordance with Tariff No 635/2011 - 18.2.2013

Rules concerning reduction of fees collected in accordance with Tariff No 635/2011 have been changed, i.e. the implementation of certain parts of the rules is postponed until 1 February 2014.

Specific symbol to label risk communication in Iceland - 18.12.2012

All Marketing Authorization Holders (MAH) are invited and encouraged to use this symbol

See All